HK1167644A1 - 2-[[[2-[(hydroxyacetyl)amino]-4-pyridinyl]methyl]thio]-n-[4- (trifluoromethoxy)phenyl]-3-pyridinecarboxamide benzene- sulfonate, crystals of same, polymorphs thereof, and processes for production thereof 2-[[[2-[()]-4-]]]-n-[4-()]-3- - Google Patents
2-[[[2-[(hydroxyacetyl)amino]-4-pyridinyl]methyl]thio]-n-[4- (trifluoromethoxy)phenyl]-3-pyridinecarboxamide benzene- sulfonate, crystals of same, polymorphs thereof, and processes for production thereof 2-[[[2-[()]-4-]]]-n-[4-()]-3-Info
- Publication number
- HK1167644A1 HK1167644A1 HK12108284.4A HK12108284A HK1167644A1 HK 1167644 A1 HK1167644 A1 HK 1167644A1 HK 12108284 A HK12108284 A HK 12108284A HK 1167644 A1 HK1167644 A1 HK 1167644A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- hydroxyacetyl
- pyridinecarboxamide
- polymorphs
- trifluoromethoxy
- pyridinyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
- C07D213/82—Amides; Imides in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
- C07C303/32—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of salts of sulfonic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/01—Sulfonic acids
- C07C309/28—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C309/29—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton of non-condensed six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Diabetes (AREA)
- Pain & Pain Management (AREA)
- Hematology (AREA)
- Ophthalmology & Optometry (AREA)
- Urology & Nephrology (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2009169130 | 2009-07-17 | ||
PCT/JP2010/062071 WO2011007870A1 (ja) | 2009-07-17 | 2010-07-16 | 2-[[[2-[(ヒドロキシアセチル)アミノ]-4-ピリジニル]メチル]チオ]-n-[4-(トリフルオロメトキシ)フェニル]-3-ピリジンカルボキサミドのベンゼンスルホン酸塩、その結晶、その結晶多形およびそれらの製造方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1167644A1 true HK1167644A1 (en) | 2012-12-07 |
Family
ID=43449480
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK12108284.4A HK1167644A1 (en) | 2009-07-17 | 2012-08-23 | 2-[[[2-[(hydroxyacetyl)amino]-4-pyridinyl]methyl]thio]-n-[4- (trifluoromethoxy)phenyl]-3-pyridinecarboxamide benzene- sulfonate, crystals of same, polymorphs thereof, and processes for production thereof 2-[[[2-[()]-4-]]]-n-[4-()]-3- |
HK12108386.1A HK1167647A1 (en) | 2009-07-17 | 2012-08-28 | 2-[[[2-[(hydroxyacetyl)amino]-4-pyridinyl]methyl]thio]-n-[4- (trifluoromethoxy)phenyl]-3-pyridinecarboxamide benzene- sulfonate, crystals of same, polymorphs thereof, and processes for production thereof 2-[[[2-[()]-4-]]]-n-[4-()]-3- |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK12108386.1A HK1167647A1 (en) | 2009-07-17 | 2012-08-28 | 2-[[[2-[(hydroxyacetyl)amino]-4-pyridinyl]methyl]thio]-n-[4- (trifluoromethoxy)phenyl]-3-pyridinecarboxamide benzene- sulfonate, crystals of same, polymorphs thereof, and processes for production thereof 2-[[[2-[()]-4-]]]-n-[4-()]-3- |
Country Status (17)
Country | Link |
---|---|
US (4) | US9029398B2 (xx) |
EP (1) | EP2455368B1 (xx) |
JP (1) | JP5662719B2 (xx) |
KR (1) | KR101710740B1 (xx) |
CN (1) | CN102471273B (xx) |
AU (1) | AU2010271746B2 (xx) |
BR (1) | BR112012001159A2 (xx) |
CA (1) | CA2767992C (xx) |
EA (1) | EA019689B1 (xx) |
ES (1) | ES2554360T3 (xx) |
HK (2) | HK1167644A1 (xx) |
IN (1) | IN2012DN01152A (xx) |
MX (1) | MX2012000749A (xx) |
MY (1) | MY157122A (xx) |
NZ (1) | NZ597495A (xx) |
SG (1) | SG177576A1 (xx) |
WO (1) | WO2011007870A1 (xx) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SG11201404230QA (en) | 2012-01-31 | 2014-10-30 | Santen Pharmaceutical Co Ltd | Non-aqueous liquid composition |
EP3047850A4 (en) * | 2013-09-20 | 2017-05-10 | Santen Pharmaceutical Co., Ltd | Polyethylene glycol-containing composition |
TW201609145A (zh) | 2013-12-25 | 2016-03-16 | 參天製藥股份有限公司 | 注射劑及形成緩釋(depot)之方法 |
TWI677346B (zh) * | 2015-03-17 | 2019-11-21 | 日商參天製藥股份有限公司 | 含有多肽之醫藥組成物 |
TW201639568A (zh) * | 2015-03-18 | 2016-11-16 | 參天製藥股份有限公司 | 醫藥組成物之安定保存 |
EP3272362B1 (en) | 2015-03-18 | 2023-12-13 | Santen Pharmaceutical Co., Ltd. | Sustained-release pharmaceutical composition |
WO2016178900A1 (en) * | 2015-05-01 | 2016-11-10 | Odin Biotech | Ocular implant for delivery of pyridinecarboxamide derivative |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1717229B1 (en) * | 2004-02-17 | 2011-06-15 | Santen Pharmaceutical Co., Ltd. | Novel cyclic compound having 4-pyridylalkylthio group having (un)substituted amino introduced therein |
JP4626353B2 (ja) | 2004-02-17 | 2011-02-09 | 参天製薬株式会社 | 置換又は無置換アミノ基を導入した4−ピリジルアルキルチオ基を有する新規環式化合物 |
ES2368153T3 (es) * | 2004-02-17 | 2011-11-14 | Santen Pharmaceutical Co., Ltd. | Nuevo compuesto cíclico que presenta un grupo 4-piridilalquiltio que presenta amino (no) sustituido introducido en el mismo. |
US7906511B2 (en) | 2005-03-31 | 2011-03-15 | Santen Pharmaceutical Co., Ltd. | Cyclic compound having pyrimidinylalkylthio group |
JP4834441B2 (ja) * | 2005-03-31 | 2011-12-14 | 参天製薬株式会社 | ピリミジニルアルキルチオ基を有する新規環式化合物 |
-
2010
- 2010-07-16 CA CA2767992A patent/CA2767992C/en not_active Expired - Fee Related
- 2010-07-16 EP EP10799928.6A patent/EP2455368B1/en not_active Not-in-force
- 2010-07-16 IN IN1152DEN2012 patent/IN2012DN01152A/en unknown
- 2010-07-16 NZ NZ597495A patent/NZ597495A/xx not_active IP Right Cessation
- 2010-07-16 MX MX2012000749A patent/MX2012000749A/es active IP Right Grant
- 2010-07-16 ES ES10799928.6T patent/ES2554360T3/es active Active
- 2010-07-16 BR BR112012001159A patent/BR112012001159A2/pt not_active IP Right Cessation
- 2010-07-16 SG SG2012001467A patent/SG177576A1/en unknown
- 2010-07-16 EA EA201200146A patent/EA019689B1/ru not_active IP Right Cessation
- 2010-07-16 US US13/384,590 patent/US9029398B2/en not_active Expired - Fee Related
- 2010-07-16 WO PCT/JP2010/062071 patent/WO2011007870A1/ja active Application Filing
- 2010-07-16 JP JP2010161881A patent/JP5662719B2/ja not_active Expired - Fee Related
- 2010-07-16 MY MYPI2011006369A patent/MY157122A/en unknown
- 2010-07-16 KR KR1020127003670A patent/KR101710740B1/ko active IP Right Grant
- 2010-07-16 AU AU2010271746A patent/AU2010271746B2/en not_active Ceased
- 2010-07-16 CN CN201080031652.1A patent/CN102471273B/zh not_active Expired - Fee Related
-
2012
- 2012-08-23 HK HK12108284.4A patent/HK1167644A1/xx not_active IP Right Cessation
- 2012-08-28 HK HK12108386.1A patent/HK1167647A1/xx not_active IP Right Cessation
-
2015
- 2015-04-14 US US14/686,577 patent/US9359328B2/en not_active Expired - Fee Related
-
2016
- 2016-05-10 US US15/150,901 patent/US9546140B2/en not_active Expired - Fee Related
- 2016-12-02 US US15/368,028 patent/US9902698B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
IN2012DN01152A (en) | 2015-04-10 |
CA2767992C (en) | 2017-03-21 |
BR112012001159A2 (pt) | 2016-03-01 |
EA019689B1 (ru) | 2014-05-30 |
US9546140B2 (en) | 2017-01-17 |
US9359328B2 (en) | 2016-06-07 |
JP2011037844A (ja) | 2011-02-24 |
US20120116088A1 (en) | 2012-05-10 |
US9029398B2 (en) | 2015-05-12 |
EP2455368A1 (en) | 2012-05-23 |
JP5662719B2 (ja) | 2015-02-04 |
ES2554360T3 (es) | 2015-12-18 |
US9902698B2 (en) | 2018-02-27 |
CN102471273A (zh) | 2012-05-23 |
US20170081286A1 (en) | 2017-03-23 |
SG177576A1 (en) | 2012-02-28 |
CA2767992A1 (en) | 2011-01-20 |
MY157122A (en) | 2016-05-13 |
NZ597495A (en) | 2013-08-30 |
AU2010271746B2 (en) | 2014-07-03 |
US20150291560A1 (en) | 2015-10-15 |
WO2011007870A1 (ja) | 2011-01-20 |
EA201200146A1 (ru) | 2012-06-29 |
CN102471273B (zh) | 2014-07-16 |
HK1167647A1 (en) | 2012-12-07 |
EP2455368B1 (en) | 2015-09-16 |
US20160251314A1 (en) | 2016-09-01 |
EP2455368A4 (en) | 2013-01-09 |
MX2012000749A (es) | 2012-01-27 |
KR101710740B1 (ko) | 2017-02-27 |
KR20130025857A (ko) | 2013-03-12 |
AU2010271746A1 (en) | 2012-02-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1167647A1 (en) | 2-[[[2-[(hydroxyacetyl)amino]-4-pyridinyl]methyl]thio]-n-[4- (trifluoromethoxy)phenyl]-3-pyridinecarboxamide benzene- sulfonate, crystals of same, polymorphs thereof, and processes for production thereof 2-[[[2-[()]-4-]]]-n-[4-()]-3- | |
HK1204960A1 (en) | Process for the production of 2-[4-(3- or 2- fluorobenzyloxy)benzylamino]propanami[with high purity degree 2-[4-(3- 2-)] | |
HK1130245A1 (en) | Process for the production of 2-[4-(3-and 2-fluorobenzyloxy) benzylamino] propanamides | |
IL187845A0 (en) | Polymorphs of ethyl 3-[(2-{[4-(hexyloxycarbonylamino-iminomethyl) | |
HK1217216A1 (zh) | 用於α病毒結構蛋白表達的無啓動子盒 | |
HK1165955A1 (en) | Purification of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine 1-[2-(24-)] | |
EP2006273A4 (en) | PROCESS FOR PRODUCING ACROLEIN | |
ZA200808364B (en) | 2-(cyclic amino)-pyrimidone derivatives as TPK1 inhibitors | |
ZA201101891B (en) | The salts of n-[4-(1-cyanocyclopentyl)phenyl]-2-(4-pyridyl methyl)amino-3-pyridinecarboxamide | |
IL229395A0 (en) | Adjusted release of 4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-4)-5-n-methyl-h1 imidazol-1-yl)-3-(trifluoromethyl)phenyl] Benzamide is dissolved using organic acids | |
IL230152A (en) | METHOD FOR PREPARING n- [5- (aminosulfonyl) -4-methyl-3,1-thiazole-2-ram] n -methyl- 2 - [4 - (2-pyridinyl) phenyl] Acetamide and its monohydrate-saturated salt | |
EP2093223A4 (en) | METHOD FOR PRODUCING AN ANTHRANILAMIDE COMPOUND | |
IL197956A0 (en) | Polymorphs of nicotinic intermediates | |
EP2195309A4 (en) | SALT POLYMORPHS OF THE ESOMEPRAZOLE | |
GB0718095D0 (en) | Process for production of recombinant proteins as a soluble form | |
EP2039691A4 (en) | PROCESS FOR PREPARING A POLYMORPHIDE OF 2- (3-CYANO-4-ISOBUTYLOXYPHENYL) -4-METHYL-5-THIAZOLCARBOXYLIC ACID | |
EP2057144A4 (en) | NEW POLYMORPHIC FROM RIMONABANT | |
EP2305673A4 (en) | CRYSTAL OF A THIAZOLIDINE CONNECTION AND METHOD FOR THE PRODUCTION THEREOF | |
HK1114833A1 (en) | Process for the production of 2-(2-aminophenyl)-bicyclopropane derivatives | |
EP2311834A4 (en) | CRYSTAL OF A THIAZOLIDINE CONNECTION AND METHOD FOR THE PRODUCTION THEREOF | |
IL216661A0 (en) | Crystalline phases of 2'-{[2-(4-methoxy-phenyl)-acetylamino]-methyl}-biphenyl-2-carboxylic acid (2-pyridin-3-yl-ethyl)-amide | |
IL193682A0 (en) | Polymorphs of n-(4-chloro-3-methyl-5-isoxazolyl)2-[2-methyl-4,5-(methylenedioxy)phenylacetyl]thiophene-3-sulfonamide, sodium salt | |
EP1953150A4 (en) | PROCESS FOR THE MANUFACTURE OF 2- (4-METHYL-2-PHENYLPIPERAZIN-1-YL) PYRIDINE-3-METHANOL | |
IL206613A0 (en) | Process for the production of 4-(substituted phenyl) hexahydropyrido[2,1-c][1,4]oxazin-6-one | |
EP2011795A4 (en) | NEW METHOD FOR PRODUCING A PYRIMIDINE COMPOUND |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20190714 |